Please fill in the form with your username, your password will be send to your registered e-mail.
* Mandatory fields
Website dedicated to help patients, their family and friends about the cancer immunotherapeutic approach in an easy-to-understand format.
Website providing information about the now recruiting Non-Small Cell Lung Cancer phase III clinical study
Learn more on MAGRIT, a large scale worldwide Phase III study investigating efficacy and safety of MAGE-A3 ASCI in the treatment of Non Small Cell Lung Cancer. GSK targets the recruitment of about 2300 patients in this randomized, double-blind, placebo-controlled trial.
If this is your first time at this site, please click here to register.
Register now
For legal reasons, this page is intended solely for healthcare professionals. This is why we ask you to register.
© 2001 - 2008 GlaxoSmithKline plc. All rights reserved.